Reference Libraries

This study by researchers at Nastech Pharmaceuticals demonstrated that MatTek’s EpiAirway in vitro human tracheal/bronchial tissue equivalent can be used to accurately assess the drug permeability, tight junction modulation, and cellular toxicity of new intranasal drug formulations. The purpose of... Read More

This study by scientists at the University of Kentucky College of Pharmacy and MatTek Corp. demonstrated that MatTek’s EpiAirway in vitro human tracheal/bronchial tissue equivalent can be used to determine the potential toxicity to humans of drugs to be administered... Read More

PURPOSE: Exogenous melatonin (MT) has significant neuroprotective roles in Alzheimer’s and Parkinson’s diseases. This study investigates the delivery MT to brain via nasal route as a polymeric gel suspension using central brain microdialysis in anesthetized rats. METHODS: Micronized MT suspensions... Read More

This study by scientists at Nastech Pharmaceuticals demonstrated how MatTek’s EpiAirway human tracheal/bronchial tissue equivalent can be used to test the ability of a novel tight junction modulating (TJM) peptide to enhance the permeability of one low-molecular weight (LMW) drug... Read More

This study by researchers at Nastech Pharmaceuticals demonstrated that MatTek’s EpiAirway in vitro human tracheal/bronchial tissue equivalent can be used to assess the drug permeability and cellular toxicity of a novel drug formulation designed for intranasal delivery. The goal of... Read More